Transition to new antiretroviral drugs in HIV programmes: clinical and programmatic considerations
View/ Open
Citation
World Health Organization. (2017). Transition to new antiretroviral drugs in HIV programmes: clinical and programmatic considerations. World Health Organization. https://iris.who.int/handle/10665/255887. License: CC BY-NC-SA 3.0 IGO